ECL vs PG
Ecolab Inc. and Procter & Gamble Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | ECL | PG |
|---|---|---|
| Revenue | $16.1B | $87.0B |
| Net income | $2.1B | $16.0B |
| Gross margin | 44.5% | 50.2% |
| Net margin | 13.0% | 18.5% |
| Return on equity | 22.4% | — |
| Diluted EPS | $7.28 | $6.62 |
| Dividend / share | $2.68 | $4.26 |
| Payout ratio | 36.3% | 63.8% |
| Free cash flow | $1.9B | $15.1B |
| Equity | $9.8B | — |
| Net debt / equity | 0.78× | — |
| Current ratio | 1.08× | 0.68× |
| Revenue CAGR 5y | 6.4% | 2.7% |
| Profit CAGR 5y | — | 2.3% |
PG bills 5.4× the revenue of ECL, and keeps more of each dollar of revenue as profit (18.5% against 13.0%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | ECL | PG |
|---|---|---|
| FY2025 | $16.1B | $87.0B |
| FY2024 | $15.7B | $84.3B |
| FY2023 | $15.3B | $84.0B |
| FY2022 | $14.2B | $82.0B |
| FY2021 | $12.7B | $80.2B |
| FY2020 | $11.8B | $76.1B |
| FY2019 | $12.6B | $71.0B |
| FY2018 | $12.2B | $67.7B |
| FY2017 | $13.8B | $66.8B |
| FY2016 | $13.2B | $65.1B |
Net income by year
Bottom line
| Fiscal year | ECL | PG |
|---|---|---|
| FY2025 | $2.1B | $16.0B |
| FY2024 | $2.1B | $16.0B |
| FY2023 | $1.4B | $14.9B |
| FY2022 | $1.1B | $14.7B |
| FY2021 | $1.1B | $14.7B |
| FY2020 | $-1.2B | $14.3B |
| FY2019 | $1.6B | $13.0B |
| FY2018 | $1.4B | $3.9B |
| FY2017 | $1.5B | $9.8B |
| FY2016 | $1.2B | $15.3B |